These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 8879443)
21. Health effects of trans-fatty acids: experimental and observational evidence. Mozaffarian D; Aro A; Willett WC Eur J Clin Nutr; 2009 May; 63 Suppl 2():S5-21. PubMed ID: 19424218 [TBL] [Abstract][Full Text] [Related]
22. Food sources of individual plasma phospholipid trans fatty acid isomers: the Cardiovascular Health Study. Micha R; King IB; Lemaitre RN; Rimm EB; Sacks F; Song X; Siscovick DS; Mozaffarian D Am J Clin Nutr; 2010 Apr; 91(4):883-93. PubMed ID: 20219966 [TBL] [Abstract][Full Text] [Related]
23. Effects of dietary saturated and n-6 polyunsaturated fatty acids on the incorporation of long-chain n-3 polyunsaturated fatty acids into blood lipids. Dias CB; Wood LG; Garg ML Eur J Clin Nutr; 2016 Jul; 70(7):812-8. PubMed ID: 26757835 [TBL] [Abstract][Full Text] [Related]
24. Dietary intake and the risk of coronary heart disease among the coconut-consuming Minangkabau in West Sumatra, Indonesia. Lipoeto NI; Agus Z; Oenzil F; Wahlqvist M; Wattanapenpaiboon N Asia Pac J Clin Nutr; 2004; 13(4):377-84. PubMed ID: 15563444 [TBL] [Abstract][Full Text] [Related]
25. [Trans-fatty acids--effects on coronary heart disease]. Karbowska J; Kochan Z Pol Merkur Lekarski; 2011 Jul; 31(181):56-9. PubMed ID: 21870712 [TBL] [Abstract][Full Text] [Related]
26. Does dietary trans fatty acid intake relate to the prevalence of coronary heart disease in Scotland? Bolton-Smith C; Woodward M; Fenton S; Brown CA Eur Heart J; 1996 Jun; 17(6):837-45. PubMed ID: 8781822 [TBL] [Abstract][Full Text] [Related]
27. Serum fatty acid levels, dietary style and coronary heart disease in three neighbouring areas in Japan: the Kumihama study. Nakamura T; Azuma A; Kuribayashi T; Sugihara H; Okuda S; Nakagawa M Br J Nutr; 2003 Feb; 89(2):267-72. PubMed ID: 12575911 [TBL] [Abstract][Full Text] [Related]
29. Plasma phospholipid trans fatty acids and risk of heart failure. Tokede OA; Petrone AB; Hanson NQ; Tsai MY; Weir NA; Glynn RJ; Gaziano JM; Djoussé L Am J Clin Nutr; 2013 Apr; 97(4):698-705. PubMed ID: 23446892 [TBL] [Abstract][Full Text] [Related]
30. Plasma oxysterols and angiographically determined coronary atherosclerosis: a case control study. van Poppel G; van de Vijver LP; Kosmeyer-Schuil T; Johanns ES; Kardinaal AF; van de Bovenkamp P; Kruyssen DA; Kok FJ Biomarkers; 1997; 2(6):373-8. PubMed ID: 23889156 [TBL] [Abstract][Full Text] [Related]
31. Eliminating artificial trans fatty acids in Argentina: estimated effects on the burden of coronary heart disease and costs. Rubinstein A; Elorriaga N; Garay OU; Poggio R; Caporale J; Matta MG; Augustovski F; Pichon-Riviere A; Mozaffarian D Bull World Health Organ; 2015 Sep; 93(9):614-22. PubMed ID: 26478625 [TBL] [Abstract][Full Text] [Related]
32. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. Tsimikas S; Brilakis ES; Miller ER; McConnell JP; Lennon RJ; Kornman KS; Witztum JL; Berger PB N Engl J Med; 2005 Jul; 353(1):46-57. PubMed ID: 16000355 [TBL] [Abstract][Full Text] [Related]
33. A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Sun Q; Ma J; Campos H; Hankinson SE; Manson JE; Stampfer MJ; Rexrode KM; Willett WC; Hu FB Circulation; 2007 Apr; 115(14):1858-65. PubMed ID: 17389261 [TBL] [Abstract][Full Text] [Related]
34. Serum Trans-Fatty Acid Concentration Is Elevated in Young Patients With Coronary Artery Disease in Japan. Mori K; Ishida T; Yasuda T; Hasokawa M; Monguchi T; Sasaki M; Kondo K; Nakajima H; Shinohara M; Shinke T; Irino Y; Toh R; Nishimura K; Hirata K Circ J; 2015; 79(9):2017-25. PubMed ID: 26166015 [TBL] [Abstract][Full Text] [Related]
35. The Evidence for Saturated Fat and for Sugar Related to Coronary Heart Disease. DiNicolantonio JJ; Lucan SC; O'Keefe JH Prog Cardiovasc Dis; 2016; 58(5):464-72. PubMed ID: 26586275 [TBL] [Abstract][Full Text] [Related]
36. Serum trans fatty acids, asymmetric dimethylarginine and risk of acute myocardial infarction and mortality in patients with suspected coronary heart disease: a prospective cohort study. Borgeraas H; Hertel JK; Seifert R; Berge RK; Bohov P; Ueland PM; Nygård O; Hjelmesæth J Lipids Health Dis; 2016 Feb; 15():38. PubMed ID: 26920731 [TBL] [Abstract][Full Text] [Related]
37. Temporal trend of circulating trans-fatty acids and risk of long-term mortality in general population. Wang S; Tian W; Liu Y; Yan G; Fang S; Wang Y; Yu B Clin Nutr; 2021 Mar; 40(3):1095-1101. PubMed ID: 32768317 [TBL] [Abstract][Full Text] [Related]
38. Intake of ruminant trans fatty acids and risk of coronary heart disease. Jakobsen MU; Overvad K; Dyerberg J; Heitmann BL Int J Epidemiol; 2008 Feb; 37(1):173-82. PubMed ID: 18077475 [TBL] [Abstract][Full Text] [Related]
39. Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo)lipoproteins. Rasouli M; Kiasari AM Clin Chem Lab Med; 2006; 44(1):43-50. PubMed ID: 16375584 [TBL] [Abstract][Full Text] [Related]
40. Erythrocyte membrane, plasma and atherosclerotic plaque lipid pattern in coronary heart disease. Lausada NR; Boullón S; Boullón F; Tacconi de Gómez Dumm IN Medicina (B Aires); 2007; 67(5):451-7. PubMed ID: 18051228 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]